WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H124918
CAS#: N/A
Description: SH1573 is a IDH2 inhibitor with IC50 – 4.78 nM.
Hodoodo Cat#: H124918
Name: SH1573
CAS#: N/A
Chemical Formula: C20H14F9N7O
Exact Mass: 539.11
Molecular Weight: 539.370
Elemental Analysis: C, 44.54; H, 2.62; F, 31.70; N, 18.18; O, 2.97
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: SH1573; SH 1573; SH-1573
IUPAC/Chemical Name: (S)-3-(trifluoromethyl)-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)pyrrolidin-3-ol
InChi Key: JYMLITLYJAHKBS-UHFFFAOYSA-N
InChi Code: InChI=1S/C20H14F9N7O/c21-18(22,23)12-3-1-2-11(32-12)14-33-15(31-10-4-6-30-13(8-10)19(24,25)26)35-16(34-14)36-7-5-17(37,9-36)20(27,28)29/h1-4,6,8,37H,5,7,9H2,(H,30,31,33,34,35)
SMILES Code: O[C@@](C1)(C(F)(F)F)CCN1C2=NC(C3=NC(C(F)(F)F)=CC=C3)=NC(NC4=CC=NC(C(F)(F)F)=C4)=N2
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 539.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
Wang Z, Zhang Z, Li Y, Sun L, Peng D, Du D, Zhang X, Han L, Zhao L, Lu L, Du H, Yuan S, Zhan M. Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China. Acta Pharm Sin B. 2021 Jun;11(6):1526-1540. doi: 10.1016/j.apsb.2021.03.005. Epub 2021 Mar 9. PMID: 34221866; PMCID: PMC8245910.